M7T (ASX) Ann: Mach7 Signs 7-year Contract with Trinity Health

Originally posted by SuperWealthy ↑

Only my 2c worth and of course everyone has their own ideas but my research focus is on just a handful of key indicators & if something ticks all the boxes I will go fairly hard at it, as early as possible.

The important thing I’ve learnt about research is to keep it simple and not to go into too much depth looking for evidence to support your thesis. She either ticks the boxes, or she doesn’t - I never go digging for more information that might help me rationalise a buy or sell. As long as she keeps ticking the boxes I’m unlikely to sell but the minute I see ticks missing I’m ready to exit - I’ve fallen in love with stocks in the past but they’ve broken my heart just about every time so I’ll never make that mistake again.

My simple criteria:

1. This is essential - it has to be a growth stock, preferably at the very early stages of growing revenues from a low/moderate base. This is easily researched via company presentations & then fact checking (because everyone spins their presentations) a few other sources. Costs need to be considered too, but strong growth trumps high costs & profit/earnings do not matter as much as revenues growth.

2. What is the company selling, and is it something disruptional or at least innovative? This is probably the trickiest item to verify or fact check. This relates to IP (I love to see patents) or some sort of “moat” that offers the company either an advantage or strong opportunity and this also relates very closely to number three:

3. What is the TAM? It needs to be in the billions, and I like to see a company (especially in the tech space) pushing into the US market and love to see the green shoots of pushing into a global market. Again, in company presentations but fact check the figures.

4. Management team & board: I look for people who have taken listed companies from micro cap to large cap in the past, and/or strong connections with those types of people (e.g. on the register or as part of a JV). This factor is possibly the single biggest indicator that the company will have a boom in share price at some point.

5. Recognise a red flag when you see one, because we are all going to get it wrong sometimes and we need to get the hell out when we realise we’ve blundered. For me it’s things like failing to deliver on stated objectives or constantly missing timelines, misleading wording or excessive spin on announcements, any failures in governance etc.

M7T ticks the boxes - I think the Achilles heel would be a competitive moat as they seem to have some competition or at least other players that are possibly perceived as offering a similar product but I really like the track record of management so that is a magnet for me.

Expand

@SuperWealthy - g'day again!! Hope all is well with you.

3DP has been putting a smile on my face for the past few months - and not long after many of us (including you from memory) were questioning it's progress.

Great to read these thoughts from you.

Reading through the points you make, have you had a look at CDX? Huge TAM, very switched on CEO, FDA approved, patented, and a heap of devices due out in 2021.

I think it ticks all your boxes - and I have built a pretty solid position over the past year or so.

Be great to get your thoughts on it.

PS Hopefully HTG and AXE and M7T keep kicking some goals for us.

No.	Vol.	Price($)
1	11797	61.5¢

No.

Vol.

Price($)

11797

61.5¢

Price($)	Vol.	No.
62.0¢	1316	1

Price($)

Vol.

No.

62.0¢

1316

No.	Vol.	Price($)
1	11797	0.615
4	61901	0.610
3	25773	0.605
5	17186	0.600
1	841	0.595

No.

Vol.

Price($)

11797

0.615

61901

0.610

25773

0.605

17186

0.600

841

0.595

Price($)	Vol.	No.
0.620	1316	1
0.625	11808	3
0.630	7595	1
0.640	3915	1
0.660	2749	2

Price($)

Vol.

No.

0.620

1316

0.625

11808

0.630

7595

0.640

3915

0.660

2749

(20min delay)
Last 61.5¢		Change -0.010(1.60%)		Mkt cap ! $148.3M

Open	High	Low	Value	Volume
62.0¢	62.0¢	61.5¢	$26.81K	43.28K

Ann: Mach7 Signs 7-year Contract with Trinity Health, page-75

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Mach7 Signs 7-year Contract with Trinity Health, page-75

Top Stories

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News